Synonyms: IMC-2C5
Anti-PDGFRB / CD140b (IMC-2C5) is a fully human antagonistic antibody targeting PDGFRβ It enhances antitumor activity and antiangiogenic agents in the treatment of a broad range of human cancers. MW :145.06 KD.
| Name | Citation | PDGFR | PDGFRα | PDGFRβ | Others |
|---|---|---|---|---|---|
| Dovitinib (TKI-258) | 52 | FLT3,c-Kit,VEGFR3/FLT4 | |||
| Linifanib (ABT-869) | 33 | VEGFR1/FLT1,CSF-1R,VEGFR2/KDR | |||
| Crenolanib (CP-868596) | 99 | ||||
| Masitinib | 42 | Kit,Lyn B,Abl1 | |||
| Amuvatinib (MP-470) | 21 | c-Kit (D816H),FLT3 (D835Y) | |||
| Motesanib Diphosphate (AMG-706) | 12 | VEGFR1,VEGFR2,VEGFR2/Flk1 | |||
| Orantinib (SU6668) | 21 | ||||
| CP-673451 | 36 | ||||
| Ki8751 | 21 | VEGFR2,c-Kit | |||
| Telatinib | 5 | c-Kit,VEGFR3,VEGFR2 | |||
| PP121 | 5 | Hck,VEGFR,mTOR | |||
| MK-2461 | 4 | c-Met (M1250T),c-Met (Y1235D),c-Met (Y1230H) | |||
| Tyrphostin AG 1296 | 14 | c-Kit (Swiss 3T3),FGFR (Swiss 3T3) | |||
| Tyrphostin 9 | 1 | EGFR | |||
| Dovitinib (TKI258) Lactate monohydrate | 31 | FLT3,c-Kit,FGFR1 | |||
| AZD2932 | 3 | Flt3,VEGFR-2,c-Kit | |||
| Sennoside B | 0 |
| Description |
Anti-PDGFRB / CD140b (IMC-2C5) is a fully human antagonistic antibody targeting PDGFRβ It enhances antitumor activity and antiangiogenic agents in the treatment of a broad range of human cancers. MW :145.06 KD.
|
References |
|---|
| Isotype | Human IgG1 |
|---|---|
| Source | CHO |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage | Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Sellecks selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.